Inactive Instrument
Invitae Corporation Share Price
Stocks
NVTA.Q
US46185L1035
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -25.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Spirito
CEO | Chief Executive Officer | - | - |
Hoki Luk
IRC | Investor Relations Contact | - | - |
Robert Guigley
PRN | Corporate Officer/Principal | - | 04/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/12/23 | Tax | Compliance Officer | 17,404 | 0.0061% | ||
| 20/12/23 | Tax | Chief Technology Officer | 17,404 | 0.0061% | ||
| 13/11/23 | Free | Chief Operating Officer | 850,000 | 0.3183% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -25.00% | -25.00% | - | - | 85.95K | ||
| +0.88% | -0.34% | +40.64% | +73.05% | 64.69B | ||
| -0.26% | +6.91% | +11.14% | +77.36% | 54.78B | ||
| +0.47% | +3.52% | +8.22% | +100.95% | 53.49B | ||
| -2.06% | +2.90% | +24.07% | +48.36% | 45.98B | ||
| -1.79% | +0.19% | +19.32% | +123.62% | 42.94B | ||
| -1.65% | +0.96% | +237.56% | +823.66% | 40.08B | ||
| -2.26% | -4.14% | +15.38% | +45.53% | 33.52B | ||
| -2.96% | -11.01% | +19.47% | -6.72% | 23.97B | ||
| +12.10% | +16.60% | +55.14% | +46.15% | 23.67B | ||
| Average | -2.25% | +1.27% | +47.88% | +147.99% | 42.57B | |
| Weighted average by Cap. | -0.08% | +1.62% | +45.48% | +149.73% |
Employees
1,700
















